Surrozen submits IND application for SZN-8141 in diabetic macular edema
Surrozen (SRZN) announced it submitted an IND application for SZN-8141 for the treatment of diabetic macular edema.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.